DSigDB Home
Search Gene
Collections
Browse Gene Sets
Download
Help

Gene Set: D4 : CTD - Azathioprine


Collection D4 : CTD
Chemical Name Azathioprine ( From PubChem : AZATHIOPRINE )
FDA NPC WHO Indian Australia China Traditional
Herbal
Clinical
Trail
ApprovedNotApprovedApprovedNotApprovedNotNot
Molecular
Weight
Hydrogen Bond
Donor Count
Hydrogen Bond
Acceptor Count
cLogP Lipinski Rule
277.263 g/mol 1 6 1.669 True
Structure
InChI InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)
InChIKey LMEKQMALGUDUQG-UHFFFAOYSA-N
Links

Gene (55 / 105)


⊖ Less

Source Type Unit Value Gene PMID Assay Other
CTDaffects(response to substance)ABCB1
D001379
CTDdecreases(reaction)AKT1
D001379
CTDincreases(phosphorylation)AKT1
D001379
CTDdecreases(expression)BCL2L1
D001379
CTDdecreases(expression)DPP4
D001379
CTDincreases(expression)FOS
D001379
CTDdecreases(reaction)FOXO1
D001379
CTDincreases(phosphorylation)FOXO1
D001379
CTDincreases(expression)GCLM
D001379
CTDincreases(expression)GPX2
D001379
CTDincreases(expression)GPX3
D001379
CTDincreases(expression)GSS
D001379
CTDaffects(metabolic processing)GSTA1
D001379
CTDaffects(response to substance)GSTA2
D001379
CTDaffects(metabolic processing)GSTA2
D001379
CTDaffects(response to substance)GSTM1
D001379
CTDaffects(metabolic processing)GSTM1
D001379
CTDaffects(response to substance)HLA-DQA1
D001379
CTDaffects(response to substance)HLA-DRB1
D001379
CTDdecreases(reaction)IGF1
D001379
CTDincreases(phosphorylation)IGF1
D001379
CTDdecreases(reaction)IGF1R
D001379
CTDincreases(phosphorylation)IGF1R
D001379
CTDdecreases(expression)IGF1R
D001379
CTDaffects(binding)IL12A
D001379
CTDincreases(expression)IL12A
D001379
CTDaffects(binding)IL12B
D001379
CTDincreases(expression)IL12B
D001379
CTDaffects(cotreatment)IL1A
D001379
CTDincreases(response to substance)IL1A
D001379
CTDdecreases(expression)IL4
D001379
CTDaffects(cotreatment)IL6
D001379
CTDincreases(response to substance)IL6
D001379
CTDaffects(response to substance)IMPDH1
D001379
CTDincreases(expression)IMPDH2
D001379
CTDdecreases(expression)IRS1
D001379
CTDincreases(phosphorylation)IRS1
D001379
CTDaffects(response to substance)ITPA
D001379
CTDaffects(response to substance)ITPA
D001379
CTDincreases(expression)JUN
D001379
CTDdecreases(phosphorylation)MAP2K1
D001379
CTDaffects(binding)MAPK1
D001379
CTDdecreases(reaction)MAPK1
D001379
CTDincreases(reaction)MAPK1
D001379
CTDincreases(phosphorylation)MAPK1
D001379
CTDaffects(binding)MAPK3
D001379
CTDdecreases(reaction)MAPK3
D001379
CTDincreases(reaction)MAPK3
D001379
CTDincreases(phosphorylation)MAPK3
D001379
CTDincreases(phosphorylation)MTOR
D001379
CTDaffects(mutagenesis)PTCH1
D001379
CTDaffects(binding)RAC1
D001379
CTDdecreases(reaction)RAC1
D001379
CTDdecreases(activity)RAC1
D001379
CTDaffects(response to substance)RAC1
D001379
CTDdecreases(reaction)RPS6KB1
D001379
CTDincreases(phosphorylation)RPS6KB1
D001379
CTDdecreases(expression)SLC15A1
D001379
CTDincreases(expression)SOD2
D001379
CTDaffects(binding)STAT3
D001379
CTDdecreases(reaction)STAT3
D001379
CTDincreases(expression)TNF
D001379
CTDaffects(cotreatment)TNF
D001379
CTDincreases(response to substance)TNF
D001379
CTDincreases(expression)TP53
D001379
CTDincreases(mutagenesis)TP53
D001379
CTDaffects(activity)TPMT
D001379
CTDaffects(response to substance)TPMT
D001379
CTDaffects(response to substance)TPMT
D001379
CTDaffects(response to substance)TPMT
D001379
CTDaffects(response to substance)TPMT
D001379
CTDaffects(response to substance)TPMT
D001379
CTDaffects(metabolic processing)TPMT
D001379
CTDaffects(binding)TSC2
D001379
CTDdecreases(reaction)TSC2
D001379
CTDincreases(reaction)TSC2
D001379
CTDincreases(expression)VAV1
D001379
PubChem NoneuMABCB1-GI(Protien) :
PubChem AhR Potency (uM)uM22.553AHR-GI(Protien) :
PubChem Potency-Replicate_1uM27.140AHR-GI(Protien) :
PubChem PotencyuM0.206ATAD5-GI(Protien) :
PubChem PotencyuM0.316HBB-GI(Protien) :
PubChem PotencyuM1.585HBB-GI(Protien) :
PubChem PotencyuM1.995HBB-GI(Protien) :
PubChem PotencyuM2.512HBB-GI(Protien) :
PubChem PotencyuM4.109IDH1-GI(Protien) :
PubChem NoneuMJAK2-GI(Protien) :
PubChem Ratio Potency (uM)uM7.522NFE2L2-GI(Protien) :
PubChem Potency-Replicate_1uM8.412NFE2L2-GI(Protien) :
PubChem Ratio Potency (uM)uM10.191NFE2L2-GI(Protien) :
PubChem PotencyuM27.306NFE2L2-GI(Protien) :
PubChem PotencyuM37.578NFE2L2-GI(Protien) :
PubChem NoneuMSTK33-GI(Protien) :
PubChem NoneuMTNFRSF10B-GI(Protien) :
ChEMBLPotencynM205.900ATAD5
-Target : CHEMBL1741209
ChEMBLInhibition-CYP1A2
-Target : CHEMBL3356
ChEMBLInhibition-CYP2C19
-Target : CHEMBL3622
ChEMBLInhibition-CYP2C9
-Target : CHEMBL3397
ChEMBLInhibition-CYP2D6
-Target : CHEMBL289
ChEMBLInhibition-CYP3A4
-Target : CHEMBL340
ChEMBLInhibition-CYP3A4
-Target : CHEMBL340
ChEMBLPotencynM1995.260HBB
-Target : CHEMBL4331
ChEMBLPotencynM1584.900HBB
-Target : CHEMBL4331
ChEMBLPotencynM2511.900HBB
-Target : CHEMBL4331
ChEMBLPotencynM316.200HBB
-Target : CHEMBL4331
Download gene sets gmt, text, Detailed text
Contact us
Tan Lab , Mail Stop 8117
12801 East 17th Avenue
Division of Medical Oncology , Department of Medicine
University of Colorado School of Medicine
Aurora, CO 80045, USA

* Best viewed in the latest version of Chrome (42+), Safari (8+), IE (11+) or Firefox (35+).